Philips Speech Recognition nets Bosma as new business development manager

TriMed Staff | | Health Imaging | Artificial Intelligence

Royal Philips Electronics has appointed Theo Bosma, MD, to expand its portfolio of professional services for information capturing in healthcare. He will hold the position of business development manager at Philips Speech Recognition Systems.

Bosma, who joins from Aurora, Colo.-based Health Language. Prior to working for Health Language, Bosma was global director of business development and consulting with Cerner in Kansas City, Mo., according to Philips. In addition to his healthcare documentation experience, he has global consulting experience to his position at Philips, having held a senior management position with Andersen Consulting (today Accenture) in both the United States and Europe.

With Bosma’s assistance, Philips will explore “opportunities to further innovate healthcare documentation, making clinically actionable information available to clinicians when and where they need it,” said Robert Thornton, commercial director of Philips Speech Recognition Systems.

 

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.